Current Problems in Cardiology
Volume 31, Issue 4 , Pages 274-352 , April 2006

Update on Infective Endocarditis

References 

  1. Levy D . Centenary of William Osler’s 1885 gulstonian lectures and their place in the history of bacterial endocarditis . J R Soc Med . 1985;78:1039–1046
  2. Laennec R . In:  Theophilus E ,  Balliere J editor. A treatise on mediate auscultation, and on diseases of the lungs and heart . London, Paris: V. Cornil; 1846;
  3. Lancisi G . De Subitaneis Mortibus . Rome: Libri Duo; 1709;
  4. Osler W . Gulstonian lectures on malignant endocarditis . Br Med J . 1885;I:467–470 522-6, 577-9
  5. Hogevik H , Olaison L , Andersson R , et al.   Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study . Medicine (Baltimore) . 1995;74(6):324–339
  6. Berlin JA , Abrutyn E , Strom BL , et al.   Incidence of infective endocarditis in the Delaware Valley, 1988-1990 . Am J Cardiol . 1995;76(12):933–936
  7. Delahaye F , Goulet V , Lacassin F , et al.   Characteristics of infective endocarditis in France 1991 (a one year survey) . Eur Heart J . 1995;16:394–401
  8. Hoen B , Alla F , Selton-Suty C , et al.   Changing profile of infective endocarditis (results of a 1-year survey in France) . JAMA . 2002;288(1):75–81
  9. Cabell CH , Fowler VG , Engemann JJ , et al.   Endocarditis in the elderly; Incidence, surgery, and survival in 16,921 patients over 12 years . Circulation . 2002;106(19):547
  10. Cabell CH , Jollis JG , Peterson GE , et al.   Changing patient characteristics and the effect on mortality in endocarditis . Arch Intern Med . 2002;162:90–94
  11. Hoen B , Alla F , Selton-Suty C , et al.   Changing profile of infective endocarditis (results of a 1-year survey in France) . JAMA . 2002;288(1):75–81
  12. Strom BL , Abrutyn E , Berlin JA , et al.   Risk factors for infective endocarditis (oral hygiene and nondental exposures) . Circulation (Online) . 2000;102(23):2842–2848
  13. Lacassin F , Hoen B , Leport C , et al.   Procedures associated with infective endocarditis in adults. A case control study . Eur Heart J . 1995;16(12):1968–1974
  14. van der Meer JT , Thompson J , Valkenburg HA , et al.   Epidemiology of bacterial endocarditis in The Netherlands. II . Antecedent procedures and use of prophylaxis Arch Int Med . 1992;152(9):1869–1873
  15. Cabell C , Lerakis S , Selton-Suty C , et al.   Cardiovascular risk factors and outcomes in patients with definite endocarditis (findings from 1024 patients in the ICE Prospective Cohort Study) . Circulation . 2003;108; (17), IV-432
  16. Karchmer A . Infective endocarditis . In:  Zipes DP ,  Libby P ,  Bonow RO , et al. editor. Heart Disease . Philadelphia: Elsevier Saunders; 2005;p. 1633–1656
  17. Robard S . Blood velocity and endocarditis . Circulation . 1963;27:24
  18. Moreillon P , Que YA , Bayer AS . Pathogenesis of streptococcal and staphylococcal endocarditis . Infect Dis Clin North Am . 2002;16:297
  19. Kreikemeyer B , Klenk M , Podbielski A . The intracellular status of Streptococcus pyogenes (role of extracellular matrix-binding proteins and their regulation) . Int J Med Microbiol . 2004;294(2-3):177–188
  20. Illingworth BL , Tweden K , Schroeder RF , et al.   In vivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis . J Heart Valve Dis . 1998;7(5):524–530
  21. Grunkemeier GL , Wu Y . The Silzone effect (how to reconcile contradictory reports?) . Eur J Cardiothorac Surg . 2004;25(3):371–375
  22. Sexton DJ , Bashore TM . Infective endocarditis . In:  Topol EJ editors. Textbook of Cardiovascular Medicine . Philadelphia: Lippincott Williams and Wilkins; 2002;p. 569–593
  23. Levine DP , Crane LR , Zervos MJ . Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study . Rev Infect Dis . 1986;8:374–396
  24. Vuille C , Nidorf M , Weyman AE , et al.   Natural history of vegetations during successful medical treatment of endocarditis . Am Heart J . 1994;128(6 Pt. 1):1200–1209
  25. McKinsey DS , Ratts TE , Bisno AL . Underlying cardiac lesions in adults with infective endocarditis . Am J Med . 1987;82:681–688
  26. Weinberger I , Rotenberg Z , Zacharovitch D , et al.   Native valve infective endocarditis in the 1970s versus 1980s (underlying cardiac lesions and infecting organisms) . Clin Cardiol . 1990;13:94–98
  27. Michel PL , Acar J . Native valve disease predisposing to infective endocarditis . Eur Heart J . 1995;16(Suppl B):2–6
  28. Gordon SM , Serkey JM , Longworth DL , et al.   Early onset prosthetic valve endocarditis (the Cleveland Clinic experience 1992-1997) . Ann Thorac Surg . 2000;69(5):1388–1392
  29. Grover FL , Cohen DJ , Oprian C , et al.   Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the VA Cooperative Study on Valve Disease . J Thorac Cardiovasc Surg . 1994;108:207–214
  30. Calderwood SB , Swinski LA , Waternaux CM , et al.   Risk factors for the development of prosthetic valve endocarditis . Circulation . 1985;72(1):31–37
  31. Kassai B , Gueyffier F , Cucherat M , et al.   Comparison of bioprosthesis and mechanical valves, a meta-analysis of randomised clinical trials . Cardiovasc Surg . 2000;8(6):477–483
  32. Hollanders G , De Scheerder I , DeBuyzere M , et al.   A six years review of 53 cases of infective endocarditis (clinical, microbiological and therapeutic features) . Acta Cardiol . 1988;43:121–132
  33. Mills J , Utley J , Abbott J . Heart failure in infective endocarditis (predisposing factors, course and treatment) . Chest . 1974;66:151–159
  34. Stewart WJ , Carabello BA . Aortic valve disease . In:  Topol EJ editors. Textbook of Cardiovascular Medicine . Philadelphia, PA: Lippincott Williams and Wilkins; 2002;p. 509–528
  35. Mann T , McLaurin L , Grossman W , et al.   Assessing the hemodynamic severity of acute aortic regurgitation due to infective endocarditis . N Engl J Med . 1975;293(3):108–113
  36. Anderson DJ , Goldstein LB , Wilkinson WE , et al.   Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis . Neurology . 2003;61(10):1341–1346
  37. Cabell CH , Pond KK , Peterson GE , et al.   The risk of stroke and death in patients with aortic and mitral valve endocarditis . Am Heart J . 2001;142(1):75–80
  38. Jones HR , Siekert RG . Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges . Brain . 1989;112:1295–1315
  39. Heiro M , Nikoskelainen J , Engblom E , et al.   Neurologic manifestations of infective endocarditis (a 17 year experience in a teaching hospital in Finland) . Arch Intern Med . 2000;160:2781–2787
  40. Mathew J , Addai T , Anand A , et al.   Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users . Arch Intern Med . 1995;155(15):1641–1648
  41. Mylonakis E , Calderwood SB . Infective endocarditis in adults . N Engl J Med . 2001;345(18):1318–1330
  42. Majumdar A , Chowdhary S , Ferreira MA , et al.   Renal pathological findings in infective endocarditis . Nephrol Dial Transplant . 2000;15(11):1782–1787
  43. Pelletier L , Petersdorf R . Infective endocarditis (a review of 125 cases from the University of Washington Hospitals, 1963-72) . Medicine . 1977;56(4):287–313
  44. von Reyn CF , Levy BS , Arbeit RD , et al.   Infective endocarditis (analysis based on strict definitions) . Ann Intern Med . 1981;94:505–518
  45. Durack DT , Lukes AS , Bright DK . New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service . Am J Med . 1994;96(3):200–209
  46. Hoen B , Selton-Suty C , Danchin N , et al.   Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis . Clin Infect Dis . 1996;21(4):905–909
  47. Olaison L , Hogevik H . Comparison of the von Reyn and Duke criteria for the diagnosis of infective endocarditis (a critical analysis of 161 episodes) . Scand J Infect Dis . 1996;28(4):399–406
  48. Cecchi E , Parrini I , Chinaglia A , et al.   New diagnostic criteria for infective endocarditis. A study of sensitivity and specificity . Eur Heart J . 1997;18(7):1149–1156
  49. Li JS , Sexton DJ , Mick N , et al.   Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis . Clin Infect Dis . 2000;30(4):633–638
  50. Lambl V . Papillare exkreszenzen an der semilunar-klappe der aorta . Wien Med Wochenschr . 1856;6:244–247
  51. Pedersen WR , Walker M , Olson JD , et al.   Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis . Chest . 1991;100(2):351–356
  52. Bayer AS , Bolger AF , Taubert KA , et al.   Diagnosis and management of infective endocarditis and its complications . Circulation . 1998;98(25):2936–2948
  53. Heidenreich P , Masoudi F , Maini B , et al.   Echocardiography in patients with suspected endocarditis (a cost effectiveness analysis) . Am J Med . 1999;107:198–208
  54. Greaves K , Patel A , Celermajer D . Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis . Heart . 2003;89:273–275
  55. Kuruppu JC , Corretti M , Mackowiak P , et al.   Overuse of transthoracic echocardiography in the diagnosis of native valve endocarditis . Arch Intern Med . 2002;162(15):1715–1720
  56. Rosen AB , Fowler VG , Corey GR , et al.   Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia . Ann Intern Med . 1999;130:810–820
  57. Rohmann S , Erbel R , Darius H , et al.   Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size . J Am Soc Echocardiogr . 1991;4:465–474
  58. Vieira ML , Grinberg M , Pomerantzeff PM , et al.   Repeated echocardiographic examinations of patients with suspected infective endocarditis . Heart . 2004;90:1020–1024
  59. Kearon C , Hirsh J . Management of anticoagulation before and after elective surgery . N Engl J Med . 1997;336(21):1506–1511
  60. Jafri SM . Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy . Am Heart J . 2004;147:3–15
  61. Moreillon P , Que Y . Infective Endocarditis . Lancet . 2004;363:139–149
  62. Cabell CH , Abrutyn E . Progress toward a global understanding of infective endocarditis . Infect Dis Clin North Am . 2002;16:255–272
  63. Sanfilippo AJ , Picard MH , Newell JB , et al.   Echocardiographic assessment of patients with infectious endocarditis . J Am Coll Cardiol . 1991;18:1191–1199
  64. Tischler MD , Vaitkus PT . The ability of vegetation size on echocardiography to predict clinical complications (a meta-analysis) . J Am Soc Echocardiogr . 1997;10(5):562–568
  65. Di Salvo G , Habib G , Pergola V , et al.   Echocardiography predicts embolic events in infective endocarditis . J Am Coll Cardiol . 2001;37(4):1069–1076
  66. Heinle S , Wilderman N , Harrison JK , et al.   Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis . Am J Cardiol . 1994;74:799–801
  67. Chu V , Cabell C , Benjamin D , et al.   Early predictors of in-hospital death in infective endocarditis . Circulation . 2004;109:1745–1749
  68. Hasbun R , Vikram HR , Barakat LA , et al.   Complicated left-sided native valve endocarditis in adults (risk classification for mortality) . JAMA . 2003;289(15):1933–1940
  69. Miro J , Del Rio A , Mestres C . Infective endocarditis in intravenous drug abusers and HIV-1 infected patients . Infect Dis Clin North Am . 2002;16:273–295
  70. Cabell CH , Pond KK , Peterson GE , et al.   The risk of stroke and death in patients with aortic and mitral valve endocarditis . Am Heart J . 2001;142:75–80
  71. Fortun J , Navas E , Martinez-Beltran J , et al.   Short-course therapy for right-side endocarditis due to staphylococcus aureus in drug abusers (cloxacillin versus Glycopeptides in combination with Gentamicin) . Clin Infect Dis . 2003;33:120–125
  72. Mathew J , Abreo G , Namburi K , et al.   Results of surgical treatment for infective endocarditis in intravenous drug users . Chest . 1995;108:73–77
  73. Mestres CA , Miro JM , Pare JC , et al.   Six-year experience with cryopreserved mitral homografts in the treatment of tricuspid valve endocarditis in HIV-infected drug addicts . J Heart Valve Dis . 1999;8:575–577
  74. Olaison L , Pettersson G . Current best practices and guidelines Indications for surgical intervention in infective endocarditis . Infect Dis Clin North Am . 2002;16:453–475
  75. Arvay A , Lengyel M . Incidence and risk factors of prosthetic valve endocarditis . Eur J Cardiothorac Surg . 1988;2(5):340–346
  76. Calderwood SB , Swinski L , Waternaux C , et al.   Risk factors for the development of prosthetic valve endocarditis . Circulation . 2002;72(1):31–37
  77. Cabell C , Heidenreich P , Chu V , et al.   Increasing rates of cardiac device infections among Medicare beneficiaries (1990-1999) . Am Heart J . 2004;147:582–586
  78. Vikram HR , Buenconsejo J , Hasbun R , et al.   Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis . JAMA . 2003;290(24):3207–3214
  79. Eishi K , Kawazoe K , Kuriyama Y , et al.   Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan . J Thorac Cardiovasc Surg . 1995;110(6):1745–1755
  80. Cacoub P , Leprince P , Nataf P , et al.   Pacemaker infective endocarditis . Am J Cardiol . 1998;82(4):480–484
  81. Gillinov AM , Faber C , Sabik J , et al.   Endocarditis after mitral valve repair . Ann Thorac Surg . 2002;73:1813–1816
  82. Ferguson E , Reardon MJ , Letsou GV . The surgical management of bacterial valvular endocarditis . Curr Opin Cardiol . 2000;15(2):82–85
  83. Venezio FR , Westenfelder GO , Cook FV , et al.   Infective endocarditis in a community hospital . Arch Intern Med . 1982;142(4):789–792
  84. Kim EL , Ching DL , Pien FD . Bacterial endocarditis at a small community hospital . Am J Med Sci . 1990;299(2):87–93
  85. Watanakunakorn C , Burkert T . Infective endocarditits at a large community teaching hospital, 1980-1990 . Medicine . 1993;72:90
  86. Parker MT , Ball LC . Streptococci and aerococci associated with systemic infection in man . J Med Microbiol . 1976;9(3):275–302
  87. Tuazon CU , Gill V , Gill F . Streptococcal endocarditis (single vs. combination antibiotic therapy and role of various species) . Rev Infect Dis . 1986;8(1):54–60
  88. Klein RS , Recco RA , Catalano MT , et al.   Association of Streptococcus bovis with carcinoma of the colon . N Engl J Med . 1977;297(15):800–802
  89. Megran DW . Enterococcal endocarditis . Clin Infect Dis . 1992;15(1):63–71
  90. Maki DG , Agger WA . Enterococcal bacteremia (clinical features, the risk of endocarditis, and management) . Medicine . 1988;67(4):248–269
  91. Ugolini V , Pacifico A , Smitherman TC , et al.   Pneumococcal endocarditis update (analysis of 10 cases diagnosed between 1974 and 1984) . Am Heart J . 1986;112(4):813–819
  92. Bruyn GA , Thompson J , van der Meer JW . Pneumococcal endocarditis in adult patients. A report of five cases and review of the literature . Q J Med . 1990;74(273):33–40
  93. Choi M , Mailman TL . Pneumococcal endocarditis in infants and children . Pediatr Infect Dis J . 2004;23(2):166–171
  94. Lefort A , Mainardi JL , Selton-Suty C , et al.  The Pneumococcal Endocarditis Study Group   Streptococcus pneumoniae endocarditis in adults. A multicenter study in France in the era of penicillin resistance (1991-1998) . Medicine . 2000;79(5):327–337
  95. Stein DS , Nelson KE . Endocarditis due to nutritionally deficient streptococci (therapeutic dilemma) . Rev Infect Dis . 1987;9(5):908–916
  96. Rapeport KB , Giron JA , Rosner F . Streptococcus mitis endocarditis. Report of 17 cases . Arch Intern Med . 1986;146(12):2361–2363
  97. Sambola A , Miro JM , Tornos MP , et al.   Streptococcus agalactiae infective endocarditis (analysis of 30 cases and review of the literature, 1962-1998) . Clin Infect Dis . 2002;34(12):1576–1584
  98. Wiseman A , Rene P , Crelinsten GL . Streptococcus agalactiae endocarditis (an association with villous adenomas of the large intestine) . Ann Intern Med . 1985;103:893–894
  99. Baddour LM  The Infectious Diseases Society of America’s Emerging Infections Network . Infective endocarditis caused by beta-hemolytic streptococci . Clin Infect Dis . 1998;26(1):66–71
  100. Buu-Hoi A , Sapoetra A , Branger C , et al.   Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis . Eur J Clin Microbiol . 1982;1(2):102–106
  101. Helft G , Tabone X , Metzger JP , et al.   Gemella haemolysans endocarditis with colonic carcinoma . Eur J Med . 1993;2(6):369–370
  102. Fowler VG , Olsen MK , Corey GR , et al.   Clinical identifiers of complicated Staphylococcus aureus bacteremia . Arch Intern Med . 2003;163(17):2066–2072
  103. Fowler VG , Miro JM , Spelman D , et al.   Staphylococcus aureus endocarditis throughout the world: a product of medical progress. Report from the ICE Investigators . Abstracts of the 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections June 26-28 . 2003; Chamonix, France.
  104. Valente AM , Jain R , Scheurer M , et al.   Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia . Pediatrics . 2005;115(1):e15–e19
  105. Petti C , Fowler VG . Staphylococcus aureus bacteremia and endocarditis . Infect Dis Clin North Am . 2002;16:413–435
  106. Fernandez-Guerrero ML , Verdejo C , Azofra J , et al.   Hospital-acquired infectious endocarditis not associated with cardiac surgery (an emerging problem) . Clin Infect Dis . 1995;20(1):16–23
  107. O’Callaghan C , McDougall P . Infective endocarditis in neonates . Arch Dis Child . 1988;63(1):53–57
  108. Chu VH , Cabell CH , Abrutyn E , et al.   Native valve endocarditis due to coagulase-negative staphylococci (report of 99 episodes from the International Collaboration on Endocarditis Merged Database) . Clin Infect Dis . 2004;39(10):1527–1530
  109. Etienne J , Brun Y , El Solh N , et al.   Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis . J Clin Microbiol . 1988;26(4):613–617
  110. Van Eldere J , Peetermans WE , Struelens M , et al.   Polyclonal Staphylococcal endocarditis caused by genetic variability . Clin Infect Dis . 2000;31(1):24–30
  111. Lina B , Celard M , Vandenesch F , et al.   Infective endocarditis due to Staphylococcus capitis . Clin Infect Dis . 1992;15(1):173–174
  112. Singh VR , Raad I . Fatal Staphylococcus saprophyticus native valve endocarditis in an intravenous drug addict . J Infect Dis . 1990;162(3):783–784
  113. Anguera I , del Rio A , Miro JM , et al.   Staphylococcus lugdunensis infective endocarditis (description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles) . Heart (Br Cardiac Soc) . 2002;91(2):e10
  114. Snyder N , Atterbury CE , Pinto CJ , et al.   Increased concurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study . Gastroenterology . 1977;73(5):1107–1113
  115. Fernandez Guerrero ML , Aguado JM , Arribas A , et al.   The spectrum of cardiovascular infections due to Salmonella enterica (a review of clinical features and factors determining outcome) . Medicine . 2004;83(2):123–138
  116. Crane LR , Levine DP , Zervos MJ , et al.   Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy . Rev Infect Dis . 1986;8(3):364–373
  117. Komshian SV , Tablan OC , Palutke W , et al.   Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center . Rev Infect Dis . 1990;12(4):693–702
  118. Ellner JJ , Rosenthal MS , Lerner PI , et al.   Infective endocarditis caused by slow-growing, fastidious, Gram-negative bacteria . Medicine . 1979;58(2):145–158
  119. Parker SW , Apicella MA , Fuller CM . Haemophilus endocarditis. Two patients and complications . Arch Intern Med . 1983;143:48
  120. Vandepitte J , DeGeest H , Jousten P . Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans. Report of a case with review of the literature . J Clin Pathol . 1977;30:842
  121. Lane T , MacGregor RR , Wright D , et al.   Cardiobacterium hominis (an elusive cause of endocarditis) . J Infect Dis . 1983;6:75
  122. Jenny DB , Leterndre PW , Iverson G . Endocarditis due to Kingella species . Rev Infect Dis . 1988;10:1065–1066
  123. Patrick WD , Brown WD , Bowmer MI , et al.   Infective endocarditis due to Eikenella corrodens (case report and review of the literature) . Can J Infect Dis . 1990;1:139
  124. Wall TC , Peyton RB , Corey GR . Gonococcal endocarditis. A new look at an old disease . Medicine . 1989;68:375
  125. Morris A , Guild I . Endocarditis due to Corynebacterium pseudodiphthericum (five case reports, review and antibiotic susceptibilities of nine strains) . Rev Infect Dis . 1991;13:887
  126. Tiley SM , Kociuba KR , Heron LG , et al.   Infective endocarditis due to nontoxigenic Corynebacterium diphtheriae (report of seven cases and review) . Clin Infect Dis . 1993;16:271
  127. Carvajal A , Frederiksen W . Fatal endocarditis due to Listeria monocytogenes . Rev Infect Dis . 1988;10:616–623
  128. Griffiths JK , Daly JS , Dodge RA . Two cases of endocarditis due to Lactobacillus species (antimicrobial susceptibility, review and discussion of therapy) . Clin Infect Dis . 1992;15:220
  129. Gorby GL , Peacock JE . Erysipelothrix rhusiopathiae endocarditis (microbiologic, epidemiologic and clinical features of an occupational disease) . Rev Infect Dis . 1988;10:317–325
  130. Nastro LJ , Finegold SM . Endocarditis due to anaerobic gram-negative bacilli . Am J Med . 1982;54:482
  131. Nastro FL , Sarma RJ . Infective endocarditis due to anaerobic and microaerophilic bacteria . West J Med . 1982;137:18–23
  132. Martin GS , Mannino DM , Eaton S , et al.   The epidemiology of sepsis in the United States from 1979 through 2000 . N Engl J Med . 2003;348(16):1546–1554
  133. Pierrotti LC , Baddour LM . Fungal endocarditis, 1995-2000 . Chest . 2002;122(1):302–310
  134. Rubenstein E , Noriega ER , Simberkoff MS , et al.   Tissue penetration of amphotericin B in Candida endocarditis . Chest . 1974;66:376
  135. Moyer D , Edward JE . Fungal endocarditis . In:  Kaye D editors. Infective Endocarditis . New York: Raven Press; 1992;p. 299–312
  136. Mora-Duarte J , Betts R , Rotstein C , et al.   Comparison of caspofungin and amphotericin B for invasive candidiasis . N Engl J Med . 2002;347(25):2020–2029
  137. Herbrecht R , Denning DW , Patterson TF , et al.   Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis . N Engl J Med . 2002;347(6):408–415
  138. Carrizosa J , Levinson ME , Lawrence T , et al.   Cure of Aspergillus ustus endocarditis . Arch Intern Med . 1974;133:486
  139. McIntosh CS , Nickers PJ , Isaqacs AJ . Spirillum endocarditis . Postgrad Med J . 1975;51:645
  140. Peter O , Flepp M , Bestetti G , et al.   Q fever endocarditis (diagnostic approaches and monitoring of therapeutic effects) . Clin Invest . 1992;70:932
  141. Lepidi H , Houpikian P , Liang Z , et al.   Cardiac valves in patients with Q fever endocarditis (microbiological, molecular, and histologic studies) . J Infect Dis . 2003;187(7):1097–1106
  142. Marrie T , Raoult D . Q Fever . Clin Infect Dis . 2005;1995(20):489–490
  143. Fernandez-Guerrero ML , Muelas JM , Aquado JM . Q fever endocarditis on porcine bioprosthetic valves . Ann Intern Med . 1988;108:209–213
  144. Austin SM , Smith SM , Co B , et al.   Case report (serologic evidence of acute murine typhus infection in a patient with culture-negative endocarditis) . Am J Med Sci . 1987;293:320–323
  145. Jones RB , Priest JB , Kuo C-C . Subacute chlamydial endocarditis . JAMA . 1982;247:655
  146. Raoult D , Birg ML , La Scola B , et al.   Cultivation of the bacillus of Whipple’s disease . [comment]. [erratum appears in N Engl J Med 2000 May 18;342(20):1538] N Engl J Med . 2000;342(9):620–625
  147. Fenollar F , Lepidi H , Raoult D . Whipple’s endocarditis (review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis) . Clin Infect Dis . 2001;33(8):1309–1316
  148. Burch GE , Tsui CY . Evolution of coxsackie viral valvular and mural endocarditis in mice . Br J Exp Pathol . 1971;53:360
  149. Persand V . Two unusual case of mural endocarditis with a review of the literature . Am J Clin Pathol . 1979;53:832
  150. Pesanti EL , Smith IM . Infective endocarditis with negative blood cultures . Am J Med . 1979;66:43
  151. Van Scoy RE . Culture negative endocarditis . Mayo Clinic Proc . 1982;57:149
  152. Hoen B , Selton-Suty C , Lacassin F , et al.   Infective endocarditis in patients with negative blood cultures—analysis of 88 cases from a one-year nationwide survey in France . Clin Infect Dis . 1995;20:501–506
  153. Tunkel BR , Kaye D . Endocarditis with negative blood cultures . N Engl J Med . 1992;326:1215–1217
  154. Baddour LM , Meyer J , Henry B . Polymicrobial infective endocarditis in the 1980s . Rev Infect Dis . 1991;13:963
  155. Durack DT , Beeson PB . Experimental bacterial endocarditis. I . Colonization of a sterile vegetation Br J Exp Pathol . 1972;53(1):44–49
  156. Baddour LM , Wilson WR , Bayer AS , et al.   Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association—executive summary: endorsed by the Infectious Diseases Society of America. 1 . Circulation . 2005;111(23):3167–3184
  157. Baddour LM , Wilson WR , Bayer AS , et al.   Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. 2 . Circulation . 2005;111(23):e394–e434
  158. Le T , Bayer AS . Combination antibiotic therapy for infective endocarditis . Clin Infect Dis . 2003;36(5):615–621
  159. Andrews M , von Reyn C . Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis . Clin Infect Dis . 2001;33:203–209
  160. Roberts RB , Krieger AG , Schiller NL , et al.   Viridans streptococcal endocarditis (the role of various species, including pyridoxal-dependent streptococci) . Rev Infect Dis . 1979;1(6):955–966
  161. Harder EJ , Wilkowske CJ , Washington JA , et al.   Streptococcus mutans endocarditis . Ann Intern Med . 1974;80(3):364–368
  162. Gephart JF , Washington JA . Antimicrobial susceptibilities of nutritionally variant streptococci . J Infect Dis . 1982;146(4):536–539
  163. Lowry RW , Zoghbi WA , Baker WB , et al.   Clinical impact of transesophageal echocardiography in the diagnosis and management of infective endocarditis . Am J Cardiol . 1994;73:1089–1091
  164. Brennan RO , Durack DT . Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis . Antimicrob Agents Chemother . 1983;23(2):273–277
  165. Francioli P , Etienne J , Hoigne R , et al.   Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility . JAMA . 1992;267(2):264–267
  166. Francioli P , Ruch W , Stamboulian D . Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days (a prospective multicenter study) . Clin Infect Dis . 1995;21(6):1406–1410
  167. Sexton DJ , Tenenbaum MJ , Wilson WR , et al.  Endocarditis Treatment Consortium Group   Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci . Clin Infect Dis . 1998;27(6):1470–1474
  168. Francioli PB . Ceftriaxone and outpatient treatment of infective endocarditis . Infect Dis Clin North Am . 1993;7(1):97–115
  169. Ugolini V , Pacifico A , Smitherman TC , et al.   Pneumococcal endocarditis update (analysis of 10 cases diagnosed between 1974 and 1984) . Am Heart J . 1986;112:813–819
  170. Bruyn GAW , Thompson J , van der Meer JWM . Pneumococcal endocarditis in adult patients . A report of 5 cases and review of the literature Q J Med . 1990;74:33
  171. Martinez E , Miro JM , Almirante B , et al.   Effect of Penicllin resistance of streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults . Clin Infect Dis . 2002;35:130–139
  172. Megran D . Enterococcal endocarditis . Clin Infect Dis . 2003;15:63–71
  173. Hricak V , Kovacik J , Marx P , et al.   Endocarditis due to enterococcus faecalis (risk factors and outcome in twenty-one cases from a five year national survey) . Scand J Infect Dis . 1998;30(5):540–541
  174. Krogstad DJ , Pargwette AR . Defective killing of enterococci (a common property of antimicrobial agents acting on the cell wall) . Antimicrob Agents Chemother . 1980;17(6):965–968
  175. Wilson WR , Wilkowske CJ , Wright AJ , et al.   Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis . Ann Intern Med . 1984;100(6):816–823
  176. Olaison L , Schadewitz K  Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis . Enterococcal endocarditis in Sweden, 1995-1999 (can shorter therapy with aminoglycosides be used?) . Clin Infect Dis . 2002;34(2):159–166
  177. Watanakunakorn C , Bakie C . Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci . Antimicrob Agents Chemother . 1973;4(2):120–124
  178. Murray BE . Vancomycin-resistant enterococcal infections . N Engl J Med . 2000;342(10):710–721
  179. Babcock HM , Ritchie DJ , Christiansen E , et al.   Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid . Clin Infect Dis . 2001;32(9):1373–1375
  180. Safdar A , Bryan CS , Stinson S , et al.   Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium (treatment with chloramphenicol plus minocycline) . Clin Infect Dis . 2002;34(11):E61–E63
  181. Karchmer AW , Archer GL , Dismukes WE . Staphylococcus epidermidis causing prosthetic valve endocarditis (microbiologic and clinical observations as guides to therapy) . Ann Intern Med . 1983;98(4):447–455
  182. Wilson WR , Karchmer AW , Dajani AS , et al.  American Heart Association   Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms . JAMA . 1995;274(21):1706–1713
  183. Whitener C , Caputo GM , Weitekamp MR , et al.   Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations . Infect Dis Clin North Am . 1993;7(1):81–96
  184. Etienne J , Eykyn SJ . Increase in native valve endocarditis caused by coagulase negative staphylococci (an Anglo-French clinical and microbiological study) . Br Heart J . 1990;64(6):381–384
  185. Drinkovic D , Morris A , Pottumarthy S , et al.   Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis . J Antimicrob Chemother . 2003;52:820–825
  186. Fowler VGJ , Sanders LL , Kong LK , et al.   Infective endocarditis due to Staphylococcus aureus (59 prospectively identified cases with follow-up) . Clin Infect Dis . 1999;28(1):106–114
  187. Roder B , Wandall D , Frimodt-Moller N , et al.   Clinical features of Staphylococcus aureus endocarditis. A 10 year experience in Denmark . Arch Intern Med . 1999;159:462–469
  188. Murray HW , Wigley FM , Mann JJ , et al.   Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy . Arch Intern Med . 1976;136(4):480–483
  189. Korzeniowski O , Sande MA . Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts (a prospective study) . Ann Intern Med . 1982;97(4):496–503
  190. Steckelberg JM , Rouse MS , Tallan BM , et al.   Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis . Antimicrob Agents Chemother . 1993;37(3):554–558
  191. Nannini EC , Singh KV , Murray BE . Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy (revisiting the issue) . Clin Infect Dis . 2003;37(9):1194–1198
  192. Wilson WR , Karchmer A , Dajani AS , et al.   Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms . JAMA . 1995;274(21):1706–1713
  193. Fortun J , Navas E , Martinez-Beltran J , et al.   Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers (cloxacillin versus glycopeptides in combination with gentamicin) . Clin Infect Dis . 2001;33(1):120–125
  194. Ruiz ME , Guerrero IC , Tuazon CU . Endocarditis caused by methicillin-resistant Staphylococcus aureus (treatment failure with linezolid) . Clin Infect Dis . 2002;35(8):1018–1020
  195. Eliopoulos GM . Quinupristin-dalfopristin and linezolid (evidence and opinion) . Clin Infect Dis . 2003;36(4):473–481
  196. Drew RH , Perfect JR , Srinath L , et al.  Synercid Emergency-Use Study Group   Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy . J Antimicrob Chemother . 2000;46(5):775–784
  197. Sakamoto H , Fukuda I , Oosaka M , et al.   Risk factors and treatment of deep sternal wound infection after cardiac operation . Ann Thorac Cardiovasc Surg . 2003;9(4):226–232
  198. Levine DP , Fromm BS , Reddy BR . Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis . Ann Intern Med . 1991;115(9):674–680
  199. Ribera E , Gomez-Jimenez J , Cortes E , et al.   Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial . Ann Intern Med . 1996;125(12):969–974
  200. Dworkin RJ , Lee BL , Sande MA , et al.   Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin . Lancet . 1989;2(8671):1071–1073
  201. Heldman AW , Hartert TV , Ray SC , et al.   Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users (prospective randomized comparison with parenteral therapy) . Am J Med . 1996;101(1):68–76
  202. Karchmer AW , Longworth DL . Infections of intracardiac devices . Infect Dis Clin North Am . 2002;16(2):477–505
  203. Pelletier LL , Petersdorf RG . Infective endocarditis (a review of 125 cases from the University of Washington Hospitals, 1963-72) . Medicine . 1977;56(4):287–313
  204. Joly V , Pangon B , Vallois JM , et al.   Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis . Antimicrob Agents Chemother . 1987;31(10):1632–1639
  205. Caron F , Gutmann L , Bure A , et al.   Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase . Antimicrob Agents Chemother . 1990;34(11):2070–2074
  206. Mentec H , Vallois JM , Bure A , et al.   Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant . Antimicrob Agents Chemother . 1992;36(9):1883–1889
  207. Potel G , Caillon J , Le Gallou F , et al.   Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis . Antimicrob Agents Chemother . 1992;36(4):744–750
  208. Rodriguez C , Olcoz MT , Izquierdo G , et al.   Endocarditis due to ampicillin-resistant nontyphoid Salmonella (cure with a third-generation cephalosporin) . Rev Infect Dis . 1990;12(5):817–819
  209. Hughes CF , Noble N . Vegetectomy (an alternative surgical treatment for infective endocarditis of the atrioventricular valves in drug addicts) . J Thorac Cardiovasc Surg . 1988;95(5):857–861
  210. Bayer AS , Hirano L , Yih J . Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis . Antimicrob Agents Chemother . 1988;32(2):231–235
  211. Parr TR , Bayer AS . Mechanisms of aminoglycoside resistance in variants of Pseudomonas aeruginosa isolated during treatment of experimental endocarditis in rabbits . J Infect Dis . 1988;158(5):1003–1010
  212. Hessen MT , Pitsakis PG , Levison ME . Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin . J Infect Dis . 1988;158(3):542–548
  213. Jimenez-Lucho VE , Saravolatz LD , Medeiros AA , et al.   Failure of therapy in pseudomonas endocarditis (selection of resistant mutants) . J Infect Dis . 1986;154(1):64–68
  214. Crane LR , Levine DP , Zervos MJ , et al.   Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy . Rev Infect Dis . 1986;8:364–373
  215. Pefanis A , Giamarellou H , Karayiannakos P , et al.   Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis . Antimicrob Agents Chemother . 1993;37(2):308–313
  216. Fichtenbaum CJ , Smith MJ . Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem . Clin Infect Dis . 1992;14(1):353–354
  217. Martin GS , Mannino DM , Eaton S , et al.   The epidemiology of sepsis in the United States from 1979 through 2000 . N Engl J Med . 2003;348(16):1546–1554
  218. Ellis ME , Al Abdely H , Sandridge A , et al.   Fungal endocarditis (evidence in the world literature, 1965-1995) . Clin Infect Dis . 2001;32(1):50–62
  219. Melgar GR , Nasser RM , Gordon SM , et al.   Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital . Medicine . 1997;76(2):94–103
  220. Gumbo T , Taege AJ , Mawhorter S , et al.   Aspergillus valve endocarditis in patients without prior cardiac surgery . Medicine . 2000;79(4):261–268
  221. Raoult D , Tissot-Dupont H , Foucault C , et al.   Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections . Medicine . 2000;79(2):109–123
  222. Maurin M , Raoult D . Q fever . Clin Microbiol Rev . 1999;12(4):518–553
  223. Raoult D , Houpikian P , Tissot DH , et al.   Treatment of Q fever endocarditis (comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine) . Arch Intern Med . 1999;159(2):167–173
  224. Dajani AS , Taubert KA , Wilson W , et al.   Prevention of bacterial endocarditis (recommendations by the American Heart Association) . Clin Infect Dis . 1997;25(6):1448–1458
  225. Durack DT . Antibiotics for prevention of endocarditis during dentistry (time to scale back?) . Ann Intern Med . 1998;129(10):829–831
  226. van der Meer JT , Van Wijk W , Thompson J , et al.   Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis . Lancet . 1992;339(8786):135–139
  227. Strom BL , Abrutyn E , Berlin JA , et al.   Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study . Ann Intern Med . 1998;129(10):761–769
  228. Bayer AS . Infective endocarditis . Clin Infect Dis . 1993;17:313–320
  229. Benn M , Hagelskjaer LH , Tvede M . Infective endocarditis, 1984 through 1993 (a clinical and microbiologic survey) . J Intern Med . 1997;24:15–22
  230. Nissen H , Nielsen F , Frederiksen M , et al.   Native valve infective endocarditis in the general population (a 10-year survey of the clinical picture during the 1980s) . Eur Heart J . 1992;13:872–877
  231. Cabell CH , Abrutyn E . Progress toward a global understanding of infective endocarditis. Lessons from the International Collaboration on Endocarditis . Cardiol Clinics . 2003;21:147–158
  232. Durack DT , Lukes AS , Bright DK . New criteria for diagnosis of infective endocarditis (utilization of specific echocardiographic findings) . Am J Med . 1994;96:200–209
  233. Sachdev M , Peterson GE , Jollis JG . Imaging techniques for diagnosis of infective endocarditis . Infect Dis Clin North Am . 2002;16(2):319–337
  234. Karchmer A . Infections of prosthetic valves and intravascular devices . In:  Mandell GL ,  Bennett JE ,  Dolin R editor. Principles and Practice of Infectious Disease . New York: Churchill Livingstone; 2000;p. 907–917

 The authors have no conflict of interests to disclose.

PII: S0146-2806(05)00185-4

doi: 10.1016/j.cpcardiol.2005.12.001

Current Problems in Cardiology
Volume 31, Issue 4 , Pages 274-352 , April 2006

Article Tools

* Image Usage & Resolution